First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Cerrar esta carpeta2. Sources of information and study methodology
Ver el documentoGeneral overview of the method
Ver el documentoDefinition of respondents
Ver el documentoQuestionnaires
Ver el documentoDistribution of questionnaires
Ver el documentoInclusion criteria
Ver el documentoSample size
Ver el documentoData analysis
Abrir esta carpeta y ver su contenido3. Dissemination and uptake of the Guidelines
Abrir esta carpeta y ver su contenido4. Basic characteristics of drug donations
Abrir esta carpeta y ver su contenido5. Practical benefits as a result of the Guidelines
Ver el documento6. Drug donations which were hampered, delayed or cancelled
Abrir esta carpeta y ver su contenido7. Experiences and opinions regarding the 12-month shelf-life requirement
Abrir esta carpeta y ver su contenido8. Other suggestions to improve the Guidelines
Abrir esta carpeta y ver su contenido9. How could donation practice be further improved?
Ver el documento10. Summary of recommendations
Ver el documento11. Postscript
Ver el documentoReferences
 

General overview of the method

The review conducted by WHO is a descriptive study for which the information was collected from standardized questionnaires sent to a large number of donors, consolidators and recipients of drug donations. The information obtained through these questionnaires includes self-reported data, experiences and opinions of the respondent organizations or individuals. These data were supplemented by information already available in WHO/DAP. If clarification was needed, additional information was obtained through direct interviews with respondents, and through reports and literature reviews. The observations and conclusions derived from the questionnaires were validated with key informants and experts. The data collected do not provide an independent and objective assessment of the impact of drug donations, but represent the opinions and experiences of a large number of organizations and experts dealing with drug donations.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013